#Pharma #Semaglutide #GLP1 #DiabetesCare #Obesity #IndianPharma #HealthcareInnovation #SunPharma #PharmaTrends #100DaysChallenge,The Valuation School,Parth Verma To view or add a comment, sign in A defining moment for metabolic healthcare in India
By simultaneously activating GLP-1, GIP, and glucagon receptors, it allows researchers to investigate receptor cross-talk, intracellular cascades, and their role in glucose regulation, lipid metabolism, and energy homeostasis
However, its important to note that tirzepatide is not appropriate for everyone
I know what caused this it was the double cream I had with the desserts on both days
VanAntwerp also recommended observation on other possible underlying medical conditions